Professor Faith Gibson becomes fellow of American Academy of Nursing
18 Sep 2020, 5:48 p.m.
A senior nurse at Great Ormond Street Hospital (GOSH) has been named as a fellow of the American Academy of Nursing.
Professor Faith Gibson, who is GOSH’s Director of Research – Nursing and Allied Health, is one of only four nurses in the UK who has been made a fellow this year and joins more than 2,700 nurses globally who are experts across their field.
Joining the clinical cancer team at GOSH in 1986, Professor Gibson has held a number of different clinical, educational and research roles. She also works at the University of Surrey as a Professor of Child Health and Cancer Care.
Her acclaimed work in research focused on children’s and young people’s cancer care has already led to a fellowship with the Royal College of Nursing, and a Lifetime Achievement Award from the International Society of Paediatric Oncology.
Professor Gibson said:
"I am delighted to be a part of the 2020 Class of New Fellows. Improving the experiences of children with cancer is a passion of mine and something I will continue to do for many years to come. I am thrilled that my work has been recognised in this way and would like to extend my thanks to the American Academy of Nursing."
A committee of elected fellows at the American Academy of Nursing reviewed hundreds of applications to chose the new fellows based on their work in the health sector.
The new fellows will be recognised for their contributions to health and health care at the American Academy of Nursing’s annual conference, which is taking place virtually in late October.
Surgery in the womb for spina bifida has stopped paralysis in dozens of babies
Dozens of babies with spina bifida have been spared paralysis and other life-limiting conditions after undergoing surgery in the womb in a cutting-edge procedure made available on the NHS.
Get Active: Cancer Sports Day 2021
On 3 July 2021 the GOSH Oncology team's cancer sports day is back, reuniting UCL and GOSH patients past and present with the wide spectrum of GOSH staff involved in their care, including doctors, nurses, physios and dietitians.
Common inflammatory bowel disease treatment is linked to reduced COVID-19 antibody response
New evidence indicates the commonly-prescribed inflammatory bowel disease (IBD) drug infliximab blunts the immune system to COVID-19 infection, potentially increasing the risk of reinfection.
GOSH and Moorfields treat the UK’s youngest patient with sight-saving gene therapy
Three year old Leo and his family appear in BBC 2's DNA Family Secrets to share their journey for answers into his condition and his successful treatment with Voretigene Neparvovec